Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-07-001057
Filing Date
2007-12-28
Accepted
2007-12-28 17:28:07
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS, L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 ganaera.txt SC 13G 21348
  Complete submission text file 0000898432-07-001057.txt   23679
Mailing Address 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Business Address 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 6109415231
GENAERA CORP (Subject) CIK: 0000880431 (see all company filings)

EIN.: 133445668 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42170 | Film No.: 071332758
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice